ArticlePsychological medicine2026
Modulation of depression through the neurobiological underpinnings of the glymphatic-rumination relationship.
Article in Psychological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glymphatic system and psychiatric disorders: need for a new paradigm?Frontiers in psychiatry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlymphatic functioning is implicated in cognitive and affective functioning. Given that rumination, a major risk factor for major depressive disorder (MDD), is a cognitive process regulating information processing, knowledge of the neurobiological mechanisms underpinning the relationship among glymphatic functioning, rumination, and depression would offer significant insight into the precipitating and maintenance mechanisms of MDD.
methodsThis study recruited 53 MDD patients and 47 matched healthy controls (HCs). Diffusion Tensor Image Analysis along the Perivascular Space (DTI-ALPS) index was computed as a proxy of the glymphatic functioning. Rumination and depressive severity were evaluated using Ruminative Response Scale (RRS) and Hamilton Depression Rating Scale (HAMD), respectively. Static and dynamic functional connectivity (FC/dFC) analyses were performed, and associations with neurotransmitter maps were explored.
resultsMDD patients showed reduced glymphatic function compared to HCs, with lower glymphatic function correlating with more severe depression and rumination. Rumination mediated the glymphatic-depression relationship. Furthermore, overlapping static FC involving default mode and subcortical networks linked the glymphatic functioning and rumination. Edge-centric dynamic FC analysis showed reduced State 3 occurrence and heightened rumination, further mediating the glymphatic-rumination relationship in HCs. Both FC biomarkers spatially correlated with various neurotransmitter maps (e.g. dopamine).
conclusionsGlymphatic dysfunction may exacerbate depression by disrupting brain networks and neurotransmitter balance, trapping individuals in maladaptive rumination. Enhancing glymphatic flow (e.g. via physical exercise) could restore neurobiological health, breaking the maladaptive cycles. This highlights glymphatic functioning as a potential therapeutic target bridging neurobiology, cognition, and depression severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.